{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:51:03Z","timestamp":1786719063953,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/0028-3886.241345","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T05:11:41Z","timestamp":1550466701000},"page":"1427","source":"Crossref","is-referenced-by-count":16,"title":["Cost analysis study of neuropsychiatric drugs: Role of National List of Essential Medicines, India"],"prefix":"10.4103","volume":"66","author":[{"given":"SudhirC","family":"Sarangi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivendeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YogendraK","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.241345-1","unstructured":"WHO Global Health Expenditure Atlas 2014. Available from: http:\/\/www.who.int\/health-accounts\/atlas2014.pdf. [Last accessed on 2017 Dec 18]."},{"key":"key-10.4103\/0028-3886.241345-2","unstructured":"Health in India. National Sample Survey (NSS) 71st Round 2014. Available from: http:\/\/mospi.nic.in\/sites\/default\/files\/publication_reports\/nss_rep574.pdf. [Last accessed on 2017 Dec 18]."},{"key":"key-10.4103\/0028-3886.241345-3","unstructured":"Pharmaceuticals. India Brand Equity Foundation. Available from: https:\/\/www.ibef.org\/download\/Pharmaceutical-May-2017.pdf. [Last accessed on 2017 Dec 12]."},{"key":"key-10.4103\/0028-3886.241345-4","unstructured":"Manufacturing Units granted Certificate of Pharmaceutical Products (COPP) in various States of India. Available from: http:\/\/www.cdsco.nic.in\/writereaddata\/COPP%20Listupdated%20on12052017.pdf. [Last accessed on 2017 Dec 12]."},{"key":"key-10.4103\/0028-3886.241345-5","first-page":"877","volume-title":"Global, regional, and national burden of neurological disorders during 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015","author":"GBD","year":"2017","journal-title":"Lancet Neurol"},{"key":"key-10.4103\/0028-3886.241345-6","unstructured":"WHO medicines strategy. Revised procedure for updating WHO's Model List of Essential Drugs. Available from: http:\/\/apps.who.int\/gb\/archive\/pdf_files\/EB109\/eeb1098.pdf?ua=1. [Last accessed on 2017 Dec 19]."},{"key":"key-10.4103\/0028-3886.241345-7","unstructured":"Report of the Core-Committee for Revision of National List of Essential Medicines. November 2015. Available from: http:\/\/cdsco.nic.in\/WriteReadData\/NLEM-2015\/Recommendations.pdf. [Last accessed on 2017 Dec 19]."},{"key":"key-10.4103\/0028-3886.241345-8","unstructured":"Lowenstein DH. Seizures and Epilepsy. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo JL, editors. Harrison's Principles of Internal Medicine. 19th ed. New York: McGraw-Hill; 2015. p. 2542-59."},{"key":"key-10.4103\/0028-3886.241345-9","unstructured":"Goadsby PJ, Raskin NH. Migraine and Other Primary Headache Disorders. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo JL, editors. Harrison's Principles of Internal Medicine. 19th ed. New York: McGraw-Hill; 2015. p. 2586-98."},{"key":"key-10.4103\/0028-3886.241345-10","unstructured":"Reus VI. Mental Disorders. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo JL, editors. Harrison's Principles of Internal Medicine. 19th ed. New York: McGraw-Hill; 2015. p. 2708-23."},{"key":"key-10.4103\/0028-3886.241345-11","unstructured":"Current Index of Medical Specialties. India. 38th Year. Apr. \u2013 July 2016."},{"key":"key-10.4103\/0028-3886.241345-12","unstructured":"Current Index of Medical Specialties. Available from: https:\/\/www.mims.com\/india. [Last accessed on 2016 Dec 19."},{"key":"key-10.4103\/0028-3886.241345-13","first-page":"233","volume-title":"The defined daily dose system (DDD) for drug utilization review","author":"Wertheimer","year":"1986","journal-title":"Hosp Pharm"},{"key":"key-10.4103\/0028-3886.241345-14","unstructured":"DDD. Definition and general considerations. Available from: https:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/. [Last accessed on 2017 Jan 10]."},{"key":"key-10.4103\/0028-3886.241345-15","unstructured":"ATC. Structure and principles. WHO Collaborating Centre for Drug Statistics Methodology. Available from: https:\/\/www.whocc.no\/atc\/structure_and_principles\/. [Last accessed on 2017 Jan 19]."},{"key":"key-10.4103\/0028-3886.241345-16","unstructured":"Banode S, Chourishi A. Cost analysis of antiepileptic drugs of different brands available in India. Int J Sci Res 2016;5."},{"key":"key-10.4103\/0028-3886.241345-17","first-page":"289","volume-title":"Cost of epilepsy in patients attending a secondary-level hospital in India","author":"Krishnan","year":"2004","journal-title":"Epilepsia"},{"key":"key-10.4103\/0028-3886.241345-18","first-page":"64","volume-title":"A calm look on cost analysis of different brands of antiepileptic drugs","author":"Gupta","year":"2011","journal-title":"J MGIMS"},{"key":"key-10.4103\/0028-3886.241345-19","first-page":"684","volume-title":"Cost variation analysis of antipsychotic drugs available in Indian market: An economic perspective","author":"Shah","year":"2017","journal-title":"Int J Basic Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.241345-20","first-page":"1","volume-title":"Cost analysis of oral antidepressant drugs available in India","author":"Paunikar","year":"2015","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"key-10.4103\/0028-3886.241345-21","first-page":"1816","volume-title":"Cost variation study of antidepressant drugs","author":"Shukla","year":"2016","journal-title":"Int J Basic Clin Pharmacol"},{"key":"key-10.4103\/0028-3886.241345-22","unstructured":"NPPA fixes ceiling prices of 814 scheduled formulations. Available from: https:\/\/economictimes.indiatimes.com\/industry\/healthcare\/biotech\/pharmaceuticals\/nppa-fixes-ceiling-prices-of-814-scheduled-formulations\/articleshow\/59402801.cms. [Last accessed on 2017 Dec 15]."}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:43:22Z","timestamp":1786715002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.241345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"alternative-id":["241345"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.241345","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}